Substance use related violent deaths among racial/ethnic groups in the United States

Mowbray, Orion; Purser, Greg; Tennant, Elena; Paseda, Oluwayomi

doi:10.1016/j.addbeh.2022.107384

Cited by 1 publication

(2 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast, Black individuals were more likely to use illicit drugs (including cocaine or stimulants). 31 Differences in baseline use may be further exacerbated by disparities in SU treatment, where White individuals were more likely to undergo substance abuse treatment and with higher treatment success rate. 32 , 33 Additionally, racial and ethnic minority groups have higher SU‐related death despite similar or lower SU rates, 31 , 33 which may highlight barriers in health care and other socioeconomic inequalities.…”

Section: Discussionmentioning

confidence: 99%

“… 31 Differences in baseline use may be further exacerbated by disparities in SU treatment, where White individuals were more likely to undergo substance abuse treatment and with higher treatment success rate. 32 , 33 Additionally, racial and ethnic minority groups have higher SU‐related death despite similar or lower SU rates, 31 , 33 which may highlight barriers in health care and other socioeconomic inequalities. Racial disparities may also coincide with economic disparities based on social factors as contributors to both SU and SU+CVD, although prior studies have suggested heterogeneity in risk of SU disorder between individuals from different socioeconomic levels.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Temporal Trends in Substance Use and Cardiovascular Disease–Related Mortality in the United States

Minhas,

Kewcharoen,

Hall

et al. 2024

JAHA

View full text Add to dashboard Cite

Background There are limited data on substance use (SU) and cardiovascular disease (CVD)–related mortality trends in the United States. We aimed to evaluate SU+CVD–related deaths in the United States using the Centers for Disease Control and Prevention Wide‐Ranging, Online Data for Epidemiologic Research database. Methods and Results The Multiple Cause‐of‐Death Public Use record death certificates were used to identify deaths related to both SU and CVD. Crude, age‐adjusted mortality rates, annual percent change, and average annual percent changes with a 95% CI were analyzed. Between 1999 and 2019, there were 636 572 SU+CVD‐related deaths (75.6% men, 70.6% non‐Hispanic White individuals, 65% related to alcohol). Age‐adjusted mortality rates per 100 000 population were pronounced in men (22.5 [95% CI, 22.6–22.6]), American Indian or Alaska Native individuals (37.7 [95% CI, 37.0–38.4]), nonmetropolitan/rural areas (15.2 [95% CI, 15.1–15.3]), and alcohol‐related death (9.09 [95% CI, 9.07 to 9.12]). The overall SU+CVD‐related age‐adjusted mortality rates increased from 9.9 (95% CI, 9.8–10.1) in 1999 to 21.4 (95% CI, 21.2–21.6) in 2019 with an average annual percent change of 4.0 (95% CI, 3.7–4.3). Increases in SU+CVD‐related average annual percent change were noted across all subgroups and were pronounced among women (4.8% [95% CI, 4.5–5.1]), American Indian or Alaska Native individuals, younger individuals, nonmetropolitan areas, and cannabis and psychostimulant users. Conclusions There was a prominent increase in SU+CVD‐related mortality in the United States between 1999 and 2019. Women, non‐Hispanic American Indian or Alaska Native individuals, younger individuals, nonmetropolitan area residents, and users of cannabis and psychostimulants had pronounced increases in SU+CVD mortality.

show abstract